6533b81ffe1ef96bd127701d
RESEARCH PRODUCT
MP-03.04 The Combination Treatment of Bicalutamide Plus Carbidopa Significantly Enhances the in vivo Antitumor Activity on LNCaP Castration-resistant Prostate Cancer Xenograft Tumors Compared To Single Use of Each Drug
Ladan FazliMartin E. GleaveChristian ThomasChristian ThomasP S RennieLatif A. WafaFrancois Lamoureuxsubject
Antitumor activityOncologyDrugmedicine.medical_specialtyBicalutamidebusiness.industryUrologymedia_common.quotation_subjectmedicine.diseaseProstate cancerIn vivoInternal medicineCarbidopaLNCaPmedicineCancer researchbusinessTumor xenograftmedicine.drugmedia_commonyear | journal | country | edition | language |
---|---|---|---|---|
2011-09-01 | Urology |